Anuradha Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anuradha Gupta has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Amit Misra
Pharmaceutics and Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow 226031, India
9 shared publications - Anas Ahmad
University of Calgary, Department of Microbiology Immunology and Infectious Diseases, Calgary, Canada
4 shared publications Mradul Mohan
CSIR-Central Drug Research Institute, Lucknow, 226031, India
4 shared publicationsPushpa Gupta
National JALMA Institute of Leprosy and Other Mycobacterial Diseases, Agra, 282001, India
4 shared publications- Rehan Khan
Chemical Biology Unit, Institute of Nano Science and Technology (INST), Knowledge City, Sector 81, Mohali, Punjab 140306, India
4 shared publications Atul Kumar Agrawal
CSIR Central Drug Research Institute, Lucknow, India
3 shared publications
Latest Publications
- 25 September 2026
- Published by Elsevier in Biologicals
- Vol. 96
Globally harmonized specifications: Implementing a patient-centric, enhanced control strategy – a meeting report
- 25 September 2026
- Published by Elsevier in Biologicals
- Vol. 96
Globally harmonized specifications: Implementing a patient-centric, enhanced control strategy – a meeting report
- Open Access
- 19 June 2025
- Published by Elsevier in Nano Trends
- Vol. 11
Nanoparticles engineering strategies for lymph-node targeted cancer immunotherapy
- 19 June 2025
- Published by Elsevier in Nano Trends
- Vol. 11
Open AccessNanoparticles engineering strategies for lymph-node targeted cancer immunotherapy
- Open Access
- 28 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 540
Polymeric Hydrogels for Controlled Drug Delivery to Treat Arthritis
Rheumatoid arthritis (RA) and osteoarthritis (OA) are disabling musculoskeletal disorders that affect joints and cartilage and may lead to bone degeneration. Conventional delivery of anti-arthritic agents is limited due to short intra-articular half-life and toxicities. Innovations in polymer chemistry have led to advancements in hydrogel technology, offering a versatile drug delivery platform exhibiting tissue-like properties with tunable drug loading and high residence time properties This review discusses the advantages and drawbacks of polymeric materials along with their modifications as well as their applications for fabricating hydrogels loaded with therapeutic agents (small molecule drugs, immunotherapeutic agents, and cells). Emphasis is given to the biological potentialities of hydrogel hybrid systems/micro-and nanotechnology-integrated hydrogels as promising tools. Applications for facile tuning of therapeutic drug loading, maintaining long-term release, and consequently improving therapeutic outcome and patient compliance in arthritis are detailed. This review also suggests the advantages, challenges, and future perspectives of hydrogels loaded with anti-arthritic agents with high therapeutic potential that may alter the landscape of currently available arthritis treatment modalities.
- 28 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 540
Open AccessPolymeric Hydrogels for Controlled Drug Delivery to Treat Arthritis
Rheumatoid arthritis (RA) and osteoarthritis (OA) are disabling musculoskeletal disorders that affect joints and cartilage and may lead to bone degeneration. Conventional delivery of anti-arthritic agents is limited due to short intra-articular half-life and toxicities. Innovations in polymer chemistry have led to advancements in hydrogel technology, offering a versatile drug delivery platform exhibiting tissue-like properties with tunable drug loading and high residence time properties This review discusses the advantages and drawbacks of polymeric materials along with their modifications as well as their applications for fabricating hydrogels loaded with therapeutic agents (small molecule drugs, immunotherapeutic agents, and cells). Emphasis is given to the biological potentialities of hydrogel hybrid systems/micro-and nanotechnology-integrated hydrogels as promising tools. Applications for facile tuning of therapeutic drug loading, maintaining long-term release, and consequently improving therapeutic outcome and patient compliance in arthritis are detailed. This review also suggests the advantages, challenges, and future perspectives of hydrogels loaded with anti-arthritic agents with high therapeutic potential that may alter the landscape of currently available arthritis treatment modalities.
- 1 September 2021
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 338
Recent advances in nano-engineered approaches used for enzyme immobilization with enhanced activity
- 1 September 2021
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 338
Recent advances in nano-engineered approaches used for enzyme immobilization with enhanced activity
- 7 August 2020
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 18 (6) , 2107-2118
Inorganic nanoparticles for natural product delivery: a review
- 7 August 2020
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 18 (6) , 2107-2118
Inorganic nanoparticles for natural product delivery: a review
- 31 December 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 6 (2) , 1102-1111
Hyperbranched Polymer-Functionalized Magnetic Nanoparticle-Mediated Hyperthermia and Niclosamide Bimodal Therapy of Colorectal Cancer Cells
Functionalized magnetic nanoparticles have attracted particular interest as potential drug delivery carriers as they offer dual advantage of delivering drugs to target site complemented with magnetic hyperthermia mediated therapy. Hyperbranched polymer-functionalized magnetic nanoparticles have potential to perform dual role of killing cancer cells by hyperthermia (by magnetite core) with apoptosis (by loaded niclosamide). These are formed by co-precipitation of iron salts followed by aminocellulose grafting, branch growth and PEGylation. Nanoparticle formation was investigated by determining particle size, zeta potential and microscopic (TEM, FE-SEM and AFM) studies. Results showed that these nanocarriers were 107 ± 57 nm in size with a zeta potential of –18 mV and exist as nanoparticles. Drug loading and encapsulation efficiency was calculated as 15.28 ± 2.72% and 76.41 ± 1.84%, respectively using UV-Vis analysis. Nanoparticles were internalized into HCT116 cells as investigated using confocal microscopy and flow cytometry. Blank nanoparticles (BNPs) at the dose of 200 µg/mL were found to be cytocompatible using hTERT cells and hemocompatible. Cell viability study suggested that niclosamide-loaded functionalized magnetic nanoparticles (NFMNPs) were more effective (7 times) than free niclosamide in killing colon cancer cells. Moreover, NFMNPs induced apoptosis in immunofluorescence study of cleaved caspase-3. Exposure of NFMNPs to alternating magnetic field (AMF) resulted in slight increase in rate of niclosamide release. AMF exposure drastically reduced cell viability due to dual effects of hyperthermia and niclosamide after treatment with NFMNPs. The potentiation of cell death due to dual effects of hyperthermia and niclosamide was further confirmed by Annexin-V/propidium iodide assay using flow cytometry. The results imply that niclosamide delivery through hyperbranched polymer-functionalized magnetic nanoparticles may serve as an effective strategy for the treatment of colorectal cancer.
- 31 December 2019
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 6 (2) , 1102-1111
Hyperbranched Polymer-Functionalized Magnetic Nanoparticle-Mediated Hyperthermia and Niclosamide Bimodal Therapy of Colorectal Cancer Cells
Functionalized magnetic nanoparticles have attracted particular interest as potential drug delivery carriers as they offer dual advantage of delivering drugs to target site complemented with magnetic hyperthermia mediated therapy. Hyperbranched polymer-functionalized magnetic nanoparticles have potential to perform dual role of killing cancer cells by hyperthermia (by magnetite core) with apoptosis (by loaded niclosamide). These are formed by co-precipitation of iron salts followed by aminocellulose grafting, branch growth and PEGylation. Nanoparticle formation was investigated by determining particle size, zeta potential and microscopic (TEM, FE-SEM and AFM) studies. Results showed that these nanocarriers were 107 ± 57 nm in size with a zeta potential of –18 mV and exist as nanoparticles. Drug loading and encapsulation efficiency was calculated as 15.28 ± 2.72% and 76.41 ± 1.84%, respectively using UV-Vis analysis. Nanoparticles were internalized into HCT116 cells as investigated using confocal microscopy and flow cytometry. Blank nanoparticles (BNPs) at the dose of 200 µg/mL were found to be cytocompatible using hTERT cells and hemocompatible. Cell viability study suggested that niclosamide-loaded functionalized magnetic nanoparticles (NFMNPs) were more effective (7 times) than free niclosamide in killing colon cancer cells. Moreover, NFMNPs induced apoptosis in immunofluorescence study of cleaved caspase-3. Exposure of NFMNPs to alternating magnetic field (AMF) resulted in slight increase in rate of niclosamide release. AMF exposure drastically reduced cell viability due to dual effects of hyperthermia and niclosamide after treatment with NFMNPs. The potentiation of cell death due to dual effects of hyperthermia and niclosamide was further confirmed by Annexin-V/propidium iodide assay using flow cytometry. The results imply that niclosamide delivery through hyperbranched polymer-functionalized magnetic nanoparticles may serve as an effective strategy for the treatment of colorectal cancer.
- 27 May 2019
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 52 (6) , 862-868
Availability of feed sources and nutritional status of Hariana cattle in different seasons in the breeding tract
The study was conducted to assess the availability of feed sources and nutritional status of Hariana cattle breed during different season in its breeding tract. The structed interview schedule was prepared to collect the information from 240 dairy farmers and the samples of available feed and fodder were collected during different season for proximate analysis. The results revealed that the fodder availibility varies according to season. The available green fodders were maize and jowar during rainy; berseem and oats during winter. The intake of nutrients were compared with requirements of Hariana cattle to find out the nutritional status during different season. The results revealed that the animals were underfed in different seasons. Dry matter intake (DMI) was deficit in all seasons; deficiency of DMI (%) was 21.46, 13.84 and 8.60 during summer, winter and rainy respectively. Total digestible nutrient intake was in excess during rainy and winter season and deficit during summer. Crude protein intake was in excess during winter; deficit in rainy and summer. The intake of Ca and P was less as compared to requirements. The information from the present study might be useful for formulation of balanced ration for Hariana breed of cattle.
- 27 May 2019
- Published by Taylor & Francis in Biological Rhythm Research
- Vol. 52 (6) , 862-868
Availability of feed sources and nutritional status of Hariana cattle in different seasons in the breeding tract
The study was conducted to assess the availability of feed sources and nutritional status of Hariana cattle breed during different season in its breeding tract. The structed interview schedule was prepared to collect the information from 240 dairy farmers and the samples of available feed and fodder were collected during different season for proximate analysis. The results revealed that the fodder availibility varies according to season. The available green fodders were maize and jowar during rainy; berseem and oats during winter. The intake of nutrients were compared with requirements of Hariana cattle to find out the nutritional status during different season. The results revealed that the animals were underfed in different seasons. Dry matter intake (DMI) was deficit in all seasons; deficiency of DMI (%) was 21.46, 13.84 and 8.60 during summer, winter and rainy respectively. Total digestible nutrient intake was in excess during rainy and winter season and deficit during summer. Crude protein intake was in excess during winter; deficit in rainy and summer. The intake of Ca and P was less as compared to requirements. The information from the present study might be useful for formulation of balanced ration for Hariana breed of cattle.
- 6 April 2018
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 18 (4) , 337-346
Synthetic Lethality: From Research to Precision Cancer Nanomedicine
Cancer is an evolutionary disease with multiple genetic alterations, accumulated due to chromosomal instability and/or aneuploidy and it sometimes acquires drug-resistant phenotype also. Whole genome sequencing and mutational analysis helped in understanding the differences among persons for predisposition of a disease and its treatment non-responsiveness. Thus, molecular targeted therapies came into existence. Among them, the concept of synthetic lethality have enthralled great attention as it is a pragmatic approach towards exploiting cancer cell specific mutations to specifically kill cancer cells without affecting normal cells and thus enhancing anti-cancer drug therapeutic index. Thus, this approach helped in discovering new therapeutic molecules for development of precision medicine. Nanotechnology helped in delivering these molecules to the target site in an effective concentration thus reducing off target effects of drugs, dose and dosage frequency drugs. Researchers have tried to deliver siRNA targeting synthetic lethal partner for target cancer cell killing by incorporating it in nanoparticles and it has shown efficacy by preventing tumor progression. This review summarizes the brief introduction of synthetic lethality, and synthetic lethal gene interactions, with a major focus on its therapeutic anticancer potential with the application of nanotechnology for development of personalized medicine.
- 6 April 2018
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 18 (4) , 337-346
Synthetic Lethality: From Research to Precision Cancer Nanomedicine
Cancer is an evolutionary disease with multiple genetic alterations, accumulated due to chromosomal instability and/or aneuploidy and it sometimes acquires drug-resistant phenotype also. Whole genome sequencing and mutational analysis helped in understanding the differences among persons for predisposition of a disease and its treatment non-responsiveness. Thus, molecular targeted therapies came into existence. Among them, the concept of synthetic lethality have enthralled great attention as it is a pragmatic approach towards exploiting cancer cell specific mutations to specifically kill cancer cells without affecting normal cells and thus enhancing anti-cancer drug therapeutic index. Thus, this approach helped in discovering new therapeutic molecules for development of precision medicine. Nanotechnology helped in delivering these molecules to the target site in an effective concentration thus reducing off target effects of drugs, dose and dosage frequency drugs. Researchers have tried to deliver siRNA targeting synthetic lethal partner for target cancer cell killing by incorporating it in nanoparticles and it has shown efficacy by preventing tumor progression. This review summarizes the brief introduction of synthetic lethality, and synthetic lethal gene interactions, with a major focus on its therapeutic anticancer potential with the application of nanotechnology for development of personalized medicine.